Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study.

Cancer Med · 2025 · PMC11795419 · PMID 39907261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In contrast, among 50 surgical patients who met the up‐to‐seven criteria, the median PFS was 29.4 months in the TACE group and 16.7 months in the combination group, yielding a HR of 1.57 (95% CI: 0.74–3.3; p = 0.23), which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.